Periodicidad semestral: flujo continuo.
ISSN - Electrónico: 2661-6947 / DOI: 10.36015 • LILACS BIREME (19784); LATINDEX (20666)
Introduction: Polyomavirus type BK (BKV) nephropathy is associated with renal transplant dysfunction, since donos carrying the VBK hold a risk factor of the concurrent cytomegalovirus infection. The presence of Decoy cells in urine and the VBK in plasma are the markers of polioma virus replication. Methods: Retrospective observational study focused on patients who received renal transplants in the period between January 2013 to December 2014. In order to make the diagnosis more accurate, we tested for clinical characteristics; the presence of Decoy cells in urine; polymerase chain reaction (PCR) blood test to detect the BK virus and immune histochemical test on renal biopsies. Results: Of 53 renal transplant patients, five developed nephropathy induced by human polyoma virus. Four received transplants from cadaveric donors and one from a living donor. Renal function deterioration was seen between three to seven months after the renal transplant in those patients receiving immunosuppression with mycophenolate mofetil or tacrolimus. Of the five patients, one tested positive for decoy cells in urine, and they all tested positive for plasmatic viral load. Discusion: The presence of BKV nephropathy in renal transplant patients is a secondary infection that might cause organ rejection. The diagnosis is made with specific biomarkers.
Cheng XS, Bohl DL, Storch GA, et al. Inhibitory Interactions between BK and JC Virus among Kidney Transplant Recipients. J Am Society Nephrology. 2011; 22(5):825-31.
Polo C, Pérez JL, Mielnichuk A, et al. Prevalence and patterns of polyomarvirus urinary excretion in immunocompetent adults and children. Clin Microbiol Infect 2010; 10:640.
Drachemberg CB, Hirsh HH, Ramos E, et al. Polyomavirus disease in renal transplantation: Review of Pathological findings and diagnostic methods. Hum Pathol 2011; 36:1245
Hirsch HH, Randhawa P, Infectious AST. Disease Community of Practice. BK polyomavirus in solid organ transplantation. Am. J. Transplant. 2013; 13: 179–88.
Sawinski deidre, Goral Simin, BK virus infection: an update on diagnosis and treatment, Nephrol Dial Transplant (2014) 0: 1–9
Hirsh HH, Brennan DC, Drachemberg CB, et al. Polyomavirus associated nephropathy in renal transplantation: Interdisciplinary analysis and recommendations.Transplantation 2009; 79:1277.
Soleymanian T, Keyvani H, Jazayeri SM, et al. Prospective study of BK virus infection and nephropathy during the first year after kidney transplantation, Iran J Kidney Dis. 2014 May; 8(3):260.
Knoll GA, Humar A, Fergusson D, et al. Levofloxacin for BK virus prophylaxis following kidney transplantation: a randomized clinical trial. JAMA 2014; 312:2106
Stuyver LJ, Verbeke T, Van Loy T, et al. An antibody response to human polyomavirus 15-mer peptides is highly abundant in healthy human subjects. Virol J 2013, 10:192.
Ferenczy MW, Marshall LJ, Nelson CD, et al. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin Microbiol Rev 2012, 5(3):471–506
Sis B, Mengel M, Haas M et al. Banff ’09 meeting report: Antibody mediated graft deterioration and implementation of Banff working groups. Am. J. Transplant. 2010; 10: 464–71.
Schaub S, Hirsch HH, Dicknmann M et al. Reducing immunosuppression preserves allograft function in presumptive and definitive polyomavirus-associated nephropathy. Am. J. Transplant. 2010; 10: 2615–23.
Hassan S, Mittal C, Amer S et al. Currently recommended BK virus (BKV) plasma viral load cutoff of ≥4 log 10m/L underestimates the diagnosis of BKV - associated nephropathy: A single transplant center experience. Transpl. Infect. Dis. 2014; 16: 5–60.
Menter T, Mayr M, Schaub S, et al. Pathology of resolving polyomavirus-associated nephropathy. Am. J. Transplant. 2013; 13: 1474–83.
Elfadawy N, Flechner SM, Liu X et al. The impact of surveillance and rapid reduction in immunosuppression to control BK virus-related graft injury in kidney transplantation. Transpl. Int. 2013; 26: 822–32.
Masutani Kosuke, Current problems in screening, diagnosis and treatment of polyomavirus BK nephropathy. Nephrology 19, Suppl. 3 (2014) 11–16.19.
Remund KF, Best M, Egan JJ. Infections relevant to lung transplantation. Proc Am Thorac Soc 2009; 6: 94–100 20.
Wiseman AC. Polyomavirus Nephropathy: a current perspective and clinical considerations. Am J Kidney Dis 2009; 54: 131–142
Hirsch HH, Randhawa P, and The AST Infectious Diseases Community of Practice. BK polyomavirus in solid organ transplantation. Am J Transplant 2013; 13: 179–188 Kuppachi S, Thomas B, Kokko KE. BK virus in the kidney transplant patient. Am J Med Sci 2013; 345: 482–488
Trofe-Clark J, Sparkes T, Gentile C et al. BK virus genotype variance and discordant BK viremia PCR assay results. Am J Transplant 2013; 13: 1112–111321. Randhawa P, Kant J, Shapiro R et al. Impact of genomic sequence variability on quantitative PCR assays for diagnosis of polyomavirus BK infection. J Clin Microbiol 2011; 49: 4072–4076
Schachtner T, Muller K, Stein M et al. BKV specific immunity kinetics: a predictor of recovery from polyomavirus BK associated nephropathy. AmJ Transplant 2011; 11: 2443–2452
Trydzenskaya H, Sattler A, Muller K et al. Novel approach for improved assessment of phenotypic and functional characteristics of BKV specific T cell immunity. Transplantation 2011; 92: 1269–1277.
The authors who publish in this journal accept the following conditions:
1. The authors retain the copyright and grant to the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM the right of the first publication, with the work registered with the Creative Commons attribution license, which allows third parties to use the published material provided that they mention the authorship of the work and the first publication in this journal.
2. Authors can make other independent and additional contractual agreements for the non-exclusive distribution of the version of the article published in this journal (for example, include it in an institutional repository or publish it in a book) as long as it clearly indicates that the work was published. for the first time in the CAMbios MEDICAL-SCIENTIFIC JOURNAL HECAM.